Presentation

“The Prix Galien Africa rewards excellence and innovation.”

Purposes

It aims to reward researchers, institutions and pharmaceutical industries from the public or private sector that have successfully developed initiatives, services, pharmaceutical, biotechnological, phytotherapy, diagnostic products, medical devices and digital solutions recently introduced on the African market.

In keeping with the spirit of the Prix Galien Africa’s mission, one special distinction may be awarded per edition. It may be proposed by the Jury to the Honorary Committee and whose criteria are defined by the Jury.

What are the prizes ?

Four prizes are awarded

The Board awards prizes in the following categories :

  • the best pharmaceutical product,
  • the best traditherapy product,
  • the best biotechnology product,
  • the best medical technology or digital solution (medical device, diagnostic, e-health, telemedicine, patient records, etc.)

The Prix Galien Africa aims to reward researchers, institutions and pharmaceutical industries from the public or private sector that have successfully developed initiatives, services, pharmaceutical, biotechnological, phytotherapy, diagnostic products, medical devices and digital solutions recently introduced on the African market.

Pharmaceuticals, biotechnology, phytotherapy, diagnostics, medical devices and digital solutions must be based on innovative science, or developed through synthetic chemistry or molecular biology or made naturally with plants according to specific criteria, specifications, tested in controlled clinical trials and marketed by ethical pharmaceutical companies.

The product or device initial marketing authorization (MA) must be valid for a maximum of five years as of December 31 of the competition year.

Evaluation criteria

The Prix Galien Africa rewards pharmaceutical sciences that improve the human condition, mainly on the basis of two criteria:

  • Innovation and/or discovery
  • Impact on the African continent.

The following will not be taken into consideration:

  • the size of the market,
  • the size of the company,
  • development costs or awarding contingencies.

Depending on the results of the Jury’s (Board) evaluation of the entries, the Jury may decide not to award a prize in a category in a given year.

The Jury is sovereign.

Decisions concerning the choice of winners are final.

The deliberations of the Jury shall take place in camera.

Apart from the members of the Jury, no other member, whether from a Prix Galien Africa governing body or sponsor, shall participate in the deliberations.

Ours Partners

Bill & Melinda Gates Foundation
OOAS
The Galien Foundation